Our publications

Citation

BibTex format

@article{Rees:2021:10.1136/archdischild-2020-319213,
author = {Rees, P and Carter, B and Gale, C and Petrou, S and Sutcliffe, A},
doi = {10.1136/archdischild-2020-319213},
journal = {Archives of Disease in Childhood: Fetal and Neonatal Edition},
pages = {494--500},
title = {Cost of neonatal abstinence syndrome: an economic analysis of English national data held in the National Neonatal Research Database},
url = {http://dx.doi.org/10.1136/archdischild-2020-319213},
volume = {106},
year = {2021}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Objective To determine the incidence of neonatal abstinence syndrome (NAS) across neonatal units, explore healthcare utilisation and estimate the direct cost to the NHS.Design Population cohort study.Setting NHS neonatal units, using data held in the National Neonatal Research Database.Participants Infants born between 2012 and 2017, admitted to a neonatal unit in England, receiving a diagnosis of NAS (n=6411).Main outcome measures Incidence, direct annual cost of care (£, 2016–2017 prices), duration of neonatal unit stay (discharge HR), predicted additional cost of care, and odds of receiving pharmacotherapy.Results Of 524 334 infants admitted during the study period, 6411 had NAS. The incidence (1.6/1000 live births) increased between 2012 and 2017 (β=0.07, 95% CI (0 to 0.14)) accounting for 12/1000 admissions and 23/1000 cot days nationally. The direct cost of care was £62 646 661 over the study period. Almost half of infants received pharmacotherapy (n=2631; 49%) and their time-to-discharge was significantly longer (median 18.2 vs 5.1 days; adjusted HR (aHR) 0.16, 95% CI (0.15 to 0.17)). Time-to-discharge was longer for formula-fed infants (aHR 0.73 (0.66 to 0.81)) and those discharged to foster care (aHR 0.77 (0.72 to 0.82)). The greatest predictor of additional care costs was receipt of pharmacotherapy (additional mean adjusted cost of £8420 per infant).Conclusions This population study highlights the substantial cot usage and economic costs of caring for infants with NAS on neonatal units. A shift in how healthcare systems provide routine care for NAS could benefit infants and families while alleviating the burden on services.
AU  - Rees,P
AU  - Carter,B
AU  - Gale,C
AU  - Petrou,S
AU  - Sutcliffe,A
DO  - 10.1136/archdischild-2020-319213
EP  - 500
PY  - 2021///
SN  - 1359-2998
SP  - 494
TI  - Cost of neonatal abstinence syndrome: an economic analysis of English national data held in the National Neonatal Research Database
T2  - Archives of Disease in Childhood: Fetal and Neonatal Edition
UR  - http://dx.doi.org/10.1136/archdischild-2020-319213
UR  - http://hdl.handle.net/10044/1/86590
VL  - 106
ER  -

Download

General enquiries

Neonatal Medicine Research Group and Neonatal Data Analysis Unit Manager
(All research related queries)
Room G 4.3
Chelsea and Westminster Hospital

Research Communications Lead
(Communications related queries only)
dsakyi@imperial.ac.uk

Our publications

Citation

BibTex format

RIS format (EndNote, RefMan)

General enquiries

Faculty of Medicine

Find us on social media